(Q40457021)

English

Impairment, disability, or handicap in peripheral neuropathy: analysis of the use of outcome measures in clinical trials in patients with peripheral neuropathies

scientific article published on August 1, 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

1 reference

Europe PubMed Central

Impairment, disability, or handicap in peripheral neuropathy: analysis of the use of outcome measures in clinical trials in patients with peripheral neuropathies (English)

1 reference

10.1136/JNNP.59.2.165

https://api.crossref.org/works/10.1136/JNNP.59.2.165

21 June 2024

0 references

peripheral neuropathy

1 reference

based on heuristic

inferred from title

author name string

D. S. Molenaar

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7629531

21 June 2024

R. de Haan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7629531

21 June 2024

M. Vermeulen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7629531

21 June 2024

language of work or name

0 references

publication date

1 August 1995

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

full work available at URL

https://jnnp.bmj.com/content/jnnp/59/2/165.full.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7629531

21 June 2024

https://europepmc.org/articles/PMC485992

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7629531

21 June 2024

https://europepmc.org/articles/PMC485992?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7629531

21 June 2024

https://syndication.highwire.org/content/doi/10.1136/jnnp.59.2.165

1 reference

10.1136/JNNP.59.2.165

https://api.crossref.org/works/10.1136/JNNP.59.2.165

21 June 2024

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

59

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

2

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

165-169

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

Cerebral vascular accidents in patients over the age of 60. II. Prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Thiamine tetraphydrofurfuryl disulfide in nutritional polyneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Transdermal clonidine versus placebo in painful diabetic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Effect of myo-inositol on peripheral-nerve function in diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Controlled trial prednisolone in acute polyneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Assessment of outcome after severe brain damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

22 September 2017

Measuring quality of life in stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

25 September 2017

The effect of sorbinil treatment on red cell sorbitol levels and clinical and electrophysiological parameters of diabetic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

25 September 2017

Diabetic neuropathy: effects of intensified glycaemic control with multiple insulin injections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic Neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

Intravenous lidocaine infusion--a new treatment of chronic painful diabetic neuropathy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

Effect of the aldose reductase inhibitor, ponalrestat, on diabetic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

Long-term effects of tolrestat on symptomatic diabetic sensory polyneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

[Interobserver variation in the application of 2 disability scales in heart patients]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

15 June 2018

Effects of methylcobalamin on diabetic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

17 June 2018

Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=485992

20 August 2018

Differentiation between different pathological cerebral embolic materials using transcranial Doppler in an in vitro model

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Six-month treatment with sorbinil in asymptomatic diabetic neuropathy. Failure to improve abnormal nerve function

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mexiletine for treatment of chronic painful diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of gangliosides on diabetic peripheral neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Middle molecular weight substances and uremic polyneuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Cerebral Gangliosides in the Alcoholic Polyneuropathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ganglioside treatment in diabetic peripheral neuropathy: A multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipramine Treatment of Painful Diabetic Neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Painful Diabetic Polyneuropathy with Mixed Gangliosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Double Blind Placebo Controlled Trial of Mixed Gangliosides in Diabetic Peripheral and Autonomic Neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma exchange and prednisone in Guillain-Barré syndrome: a controlled randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of effect of mianserin on the symptoms of diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mexiletine in the treatment of diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7629531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study

24

1 reference

10.1136/JNNP.59.2.165

https://api.crossref.org/works/10.1136/JNNP.59.2.165

21 June 2024

Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome

31

1 reference

10.1136/JNNP.59.2.165

https://api.crossref.org/works/10.1136/JNNP.59.2.165

21 June 2024

Identifiers

10.1136/JNNP.59.2.165

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40457021&oldid=2185822770"